Position in JBIO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$209,667
-$11,704 QoQ
Shares Held
9,436
-40.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DELTEC ASSET MANAGEMENT LLC holds $28,179,038 across 7 Biotechnology names. JBIO ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OCUL |
Ocular Therapeutix, Inc
|
2,476,197 | $24,316,254 | |
| 2 | MNKD |
Mannkind Corp
|
628,000 | $2,675,280 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
2,400 | $366,768 | |
| 4 | LSTA |
Lisata Therapeutics, Inc.
|
83,197 | $282,869 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
15,000 | $255,000 | |
| 6 | JBIO |
Jade Biosciences, Inc.
This page
|
9,436 | $209,667 | |
| 7 | PASG |
Passage BIO, Inc.
|
15,000 | $73,200 |
All Filings in JBIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,667 | 9,436 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $221,371 | 15,756 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $243,115 | 15,756 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $135,974 | 15,756 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $157,402 | 15,756 | Shares | Sole | 2025-07-18 | |
| No filing history on record for this holder in this stock. | ||||||